Orchestra BioMed Holdings, Inc./$OBIO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Orchestra BioMed Holdings, Inc.
Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.
Ticker
$OBIO
Sector
Primary listing
Employees
86
Headquarters
Website
OBIO Metrics
BasicAdvanced
$272M
-
-$1.11
0.60
-
Price and volume
Market cap
$272M
Beta
0.6
52-week high
$5.42
52-week low
$2.20
Average daily volume
216K
Financial strength
Current ratio
6.448
Quick ratio
6.37
Long term debt to equity
23.989
Total debt to equity
25.174
Interest coverage (TTM)
-27.27%
Profitability
EBITDA (TTM)
-51.48
Gross margin (TTM)
99.43%
Net profit margin (TTM)
-157.40%
Operating margin (TTM)
-154.73%
Revenue per employee (TTM)
$390,000
Management effectiveness
Return on assets (TTM)
-33.90%
Return on equity (TTM)
-109.41%
Valuation
Price to revenue (TTM)
6.617
Price to book
4.94
Price to tangible book (TTM)
4.94
Price to free cash flow (TTM)
-4.48
Free cash flow yield (TTM)
-22.32%
Free cash flow per share (TTM)
-1.036
Growth
Revenue change (TTM)
1,169.22%
Earnings per share change (TTM)
-33.08%
3-year revenue growth (CAGR)
111.62%
3-year earnings per share growth (CAGR)
-20.92%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Orchestra BioMed Holdings, Inc. stock?
Orchestra BioMed Holdings, Inc. (OBIO) has a market cap of $272M as of March 20, 2026.
What is the P/E ratio for Orchestra BioMed Holdings, Inc. stock?
The price to earnings (P/E) ratio for Orchestra BioMed Holdings, Inc. (OBIO) stock is 0 as of March 20, 2026.
Does Orchestra BioMed Holdings, Inc. stock pay dividends?
No, Orchestra BioMed Holdings, Inc. (OBIO) stock does not pay dividends to its shareholders as of March 20, 2026.
When is the next Orchestra BioMed Holdings, Inc. dividend payment date?
Orchestra BioMed Holdings, Inc. (OBIO) stock does not pay dividends to its shareholders.
What is the beta indicator for Orchestra BioMed Holdings, Inc.?
Orchestra BioMed Holdings, Inc. (OBIO) has a beta rating of 0.6. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.